RNA interference suppression of neurodegenerative diseases and methods of use
US10072264B2 · kind B2 · utility
2Cited by
46References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 30, 2016 |
| Grant date | Sep 11, 2018 |
| Priority date | — |
| Expiry date | Dec 30, 2036 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to small interfering RNA molecules (siRNA) targeted against nucleic acid sequence that encodes huntingtin or ataxin-1, and methods of using these siRNA molecules.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.